BPC-157 is a signaling peptide, not a steroid: It works by upregulating VEGF to grow new capillaries, activating growth hormone receptors in tendon and ligament tissue, and promoting collagen synthesis
In conclusion, this review synthesizes molecular insights and clinical evidence to underscore GLP-1RAs potential as multi-targeted disease-modifying agents, urging further research to translate preclinical promise into safe, effective ocular therapies
As primary substrates for DPP-IV are GLP-1, GLP-2, and gastro-insulinotropic peptide (GIP), DPP-IV gene-deficient mice show improved postprandial glucose control and are resistant to progression of obesity and hyperinsulinemia (Drucker 2002
It is expanding the market
Liposomal or IV forms tend to have better absorption and are also considered safe when used appropriately